Does TEZEPELUMAB-EKKO Cause Therapy cessation? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Therapy cessation have been filed in association with TEZEPELUMAB-EKKO. This represents 0.3% of all adverse event reports for TEZEPELUMAB-EKKO.
13
Reports of Therapy cessation with TEZEPELUMAB-EKKO
0.3%
of all TEZEPELUMAB-EKKO reports
0
Deaths
3
Hospitalizations
How Dangerous Is Therapy cessation From TEZEPELUMAB-EKKO?
Of the 13 reports, 3 (23.1%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEZEPELUMAB-EKKO. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does TEZEPELUMAB-EKKO Cause?
Asthma (630)
Dyspnoea (382)
Arthralgia (381)
Drug ineffective (358)
Pneumonia (192)
Back pain (184)
Cough (182)
Rash (177)
Pain (148)
Product dose omission issue (146)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which TEZEPELUMAB-EKKO Alternatives Have Lower Therapy cessation Risk?
TEZEPELUMAB-EKKO vs THALIDOMIDE
TEZEPELUMAB-EKKO vs THALOMID
TEZEPELUMAB-EKKO vs THEOPHYLLINE
TEZEPELUMAB-EKKO vs THEOPHYLLINE ANHYDROUS
TEZEPELUMAB-EKKO vs THIAMINE